The potential and challenges of patient-derived organoids in guiding the multimodality treatment of upper gastrointestinal malignancies
Open Access
- 8 April 2020
- journal article
- review article
- Published by The Royal Society in Open Biology
- Vol. 10 (4), 190274
- https://doi.org/10.1098/rsob.190274
Abstract
The incidence of adenocarcinoma at the gastrooesophageal junction increased over the last years. Curative treatment for patients with upper gastrointestinal (UGI) malignancies, such as oesophageal and gastric tumours, is challenging and requires a multidisciplinary approach. Radical surgical resection with complete lymphadenectomy is the cornerstone of UGI cancer treatment. Combined with peri-operative treatment (i.e. by applying CROSS, EOX or FLOT regimen), the survival is even better than with surgery alone. However, peri-operative treatment is not effective in all patients, and the most effective strategy is a topic of active debate, as is reflected by varying treatment guidelines between countries. UGI cancers are (epi)genetically highly heterogeneous. It is thus not likely that a uniform treatment will benefit all patients equally well. Over recent years, patient-derived organoids (PDOs) gained more and more interest as an in vitro prediction model that may assist as a diagnostic tool in the future to select and eventually optimize the best peri-operative treatments for each patient. PDOs can be derived from endoscopic tumour biopsies, which maintain heterogeneity in culture. They can be rapidly established and expanded in a relatively short time for in vitro drug screening experiments. This review summarizes the clinical and molecular aspects of oesophageal and gastric tumours, as well as the current progress and remaining challenges in the use of PDOs for drug and radiation screens.Keywords
This publication has 51 references indexed in Scilit:
- Organoid Cultures Derived from Patients with Advanced Prostate CancerCell, 2014
- Comprehensive molecular characterization of gastric adenocarcinomaNature, 2014
- Whole-genome sequencing and comprehensive molecular profiling identify new driver mutations in gastric cancerNature Genetics, 2014
- Epidemiology and Risk Factors for Gastroesophageal Junction Tumors: Understanding the Rising Incidence of This DiseaseSeminars in Radiation Oncology, 2012
- Cell linesSpermatogenesis, 2012
- Long-term Expansion of Epithelial Organoids From Human Colon, Adenoma, Adenocarcinoma, and Barrett's EpitheliumGastroenterology, 2011
- Isolation and in vitro expansion of human colonic stem cellsNature Medicine, 2011
- Generation of orthotopic and heterotopic human pancreatic cancer xenografts in immunodeficient miceNature Protocols, 2009
- An In vivo Platform for Translational Drug Development in Pancreatic CancerClinical Cancer Research, 2006
- Perioperative Chemotherapy versus Surgery Alone for Resectable Gastroesophageal CancerThe New England Journal of Medicine, 2006